As the demands for more detailed protein characterization increase, many companies are working to meet those demands through new tools, technologies, and assays. Alistair Kippen, Ph.D., head of ...
Protein drugs feature significant advantages over small molecule therapeutics, including low toxicity, high specificity, and development speed. However, the quality control requirements are ...
The new cell-free protein crystallization (CFPC) method includes direct protein crystallization and is a major headway in the field of structural biology. This technique will enable the analysis of ...
GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual ...
Electron activated dissociation (EAD) offered by the ZenoTOF 7600 system is a powerful tool for comprehensive characterization of protein therapeutics. Compared to traditional low-energy ExD ...
Dr. Simon Sumer explains how AI‑driven protein design is shortening development cycles, improving screening efficiency, and ...
Industry experts highlight advances in proteomics workflows that overcome trade-offs between resolution and throughput.
DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI) has agreed to acquire the assets of San Diego-based Alliance Protein Laboratories (Alliance), a leading analytical services company ...
US scientists have built a high-throughput biological platform that could speed up the search ...